Home > Healthcare > Medical Devices > Rehabilitation and Assistive Devices > Blood Drawing Chairs Market
Blood Drawing Chairs Market was valued at around USD 172.4 million in 2023 and is anticipated to grow at a CAGR of over 5.7% between 2024 and 2032. Growing blood donation programs, focus on patient & donor comfort and safety, rising geriatric population and expansion of diagnostic laboratories are among the key factors propelling the market growth. The expansion of diagnostic facilities increases the requirement for suitable furniture, including blood drawing chairs.
Moreover, innovations in blood drawing chair design and technology attract healthcare providers seeking efficiency and donor comfort. Healthcare providers prioritize patient and donor comfort and safety, influencing the adoption of ergonomic and adjustable blood drawing chairs. Further, increasing awareness and emphasis on preventive healthcare contribute to a growing global trend in blood testing, driving the market for related equipment. In order to create awareness among citizens, the World Health Organization (WHO) has declared June 14 as World Blood Donor Day. Such initiatives and campaigns would increase the blood donation awareness among people, thus, in turn, fueling the product demand.
A blood drawing chair, also known as a phlebotomy chair, is a specialized piece of medical furniture designed for the purpose of drawing blood from patients or blood donors. These chairs are specifically crafted to provide a comfortable and secure seating arrangement for individuals undergoing blood collection procedures, such as venipuncture or phlebotomy.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Blood Drawing Chairs Market Size in 2023: | USD 172.4 Million |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 5.7% |
2032 Value Projection: | USD 285.5 Million |
Historical Data for: | 2018 to 2023 |
No. of Pages: | 130 |
Tables, Charts & Figures: | 270 |
Segments covered: | Product, Type, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|